Dizal Pharmaceutical Co Ltd Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Dizal Pharmaceutical Co Ltd

Watchlist Manager

Watchlist

Price: 67.56 CNY 5.4% Market Closed

Market Cap: ¥31.4B

D	Dizal Pharmaceutical Co Ltd SSE:688192	CN
A	Arihant Tournesol Ltd BSE:526125	IN
N	NOVA Technology Corp Ltd SZSE:300921	CN

Profitability Summary

Dizal Pharmaceutical Co Ltd's profitability score is 23/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

96%

Strong 3Y Average Gross Margin

96%

Gross Margin is Increasing

94% > 96%

Negative Operating Margin

-62%

Negative 3Y Average Operating Margin

-315%

Operating Margin is Increasing

-2 688% > -62%

Negative Net Margin

-62%

Negative 3Y Average Net Margin

-304%

Net Margin is Increasing

-2 630% > -62%

Negative Free Cash Flow Margin

-73%

Negative 3Y Average Free Cash Flow Margin

-283%

Free Cash Flow Margin is Increasing

-2 208% > -73%

Negative ROE

-43%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-117%

ROIC is Increasing

-201% > -71%

View All

Hide

Collapse

23 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

96%

Strong 3Y Average Gross Margin

96%

Gross Margin is Increasing

94% > 96%

Negative Operating Margin

-62%

Negative 3Y Average Operating Margin

-315%

Operating Margin is Increasing

-2 688% > -62%